Herndon Capital Management’s CVS Health CVS Stock Holding History

Herndon Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-99	Closed	-$9K	–	292
2016 Q3	$9K	Hold	99	–	–	﹤0.01%	180
2016 Q2	$9K	Buy	+99	New	+$9.87K	﹤0.01%	191

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Herndon Capital Management's CVS Position: Q4 2016 in Review

Herndon Capital Management sold out of CVS Health (CVS) in Q4 2016, closing a stake of 99 shares — an estimated $9K sold.

Herndon Capital Management first reported a position in CVS in Q2 2016 and held it in 2 quarters. The position peaked at $9K in Q3 2016. 1,549 funds tracked by Wall St. Rank hold CVS as of Q4 2016.

Herndon Capital Management reported no remaining CVS Health position as of Q4 2016 after selling out during the quarter.
Herndon Capital Management sold 99 CVS Health shares in Q4 2016, an estimated $9K.
Herndon Capital Management first reported a position in CVS Health in Q2 2016 and held it in 2 quarters.
Herndon Capital Management's CVS Health position peaked at $9K in Q3 2016.
1,549 funds tracked by Wall St. Rank held CVS Health as of Q4 2016.

Based on Herndon Capital Management's 13F filing for Q4 2016, filed 2 Feb 2017.